Clinical Trial

CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, open-label, first-in-human, dose-escalation study in patients with pancreatic cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-06; most recent amendment 2025-06-03.
Status change: Not Yet Recruiting → Recruiting 2025-05-18
Trial Details
NCT Number NCT06816823
Lead Sponsor Changhai Hospital
Conditions Pancreatic Cancer
Enrollment 30 participants
Start Date 2025-04-07
Primary Completion 2025-09 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-04